A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature

A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature

Abstract The human cytochrome P450 2D6 (CYP2D6) enzyme is part of phase-I metabolism and metabolizes at least 20% of all clinically relevant drugs. Therefore, it is an important target for drug-drug interaction (DDI) studies. High-throughput screening (HTS) assays are commonly used tools to examine...

Full description

Saved in:
Bibliographic Details
Main Authors: Johannes Hochleitner, Muhammad Akram, Martina Ueberall, Rohan A. Davis, Birgit Waltenberger, Hermann Stuppner, Sonja Sturm, Florian Ueberall, Johanna M. Gostner, Daniela Schuster
Format: article
Language:EN
Published: Nature Portfolio 2017
Subjects:
Medicine
R
Science
Q
Online Access:https://doaj.org/article/33a551dcc5004dd0b9cac26fa715e9a5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items